Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Return on Equity (2021 - 2025)

Historic Return on Equity for Rapid Micro Biosystems (RPID) over the last 5 years, with Q3 2025 value amounting to 0.9%.

  • Rapid Micro Biosystems' Return on Equity fell 3600.0% to 0.9% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.9%, marking a year-over-year decrease of 3600.0%. This contributed to the annual value of 0.49% for FY2024, which is 1100.0% down from last year.
  • Latest data reveals that Rapid Micro Biosystems reported Return on Equity of 0.9% as of Q3 2025, which was down 3600.0% from 0.73% recorded in Q2 2025.
  • Over the past 5 years, Rapid Micro Biosystems' Return on Equity peaked at 0.31% during Q1 2022, and registered a low of 2.0% during Q3 2021.
  • Its 5-year average for Return on Equity is 0.57%, with a median of 0.43% in 2023.
  • In the last 5 years, Rapid Micro Biosystems' Return on Equity skyrocketed by 16900bps in 2022 and then plummeted by -3600bps in 2025.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' Return on Equity stood at 0.32% in 2021, then fell by -10bps to 0.35% in 2022, then fell by -20bps to 0.43% in 2023, then plummeted by -38bps to 0.59% in 2024, then plummeted by -53bps to 0.9% in 2025.
  • Its last three reported values are 0.9% in Q3 2025, 0.73% for Q2 2025, and 0.64% during Q1 2025.